Chemotherapy Shows a Better Efficacy Than Endocrine Therapy in Metastatic Breast Cancer Patients with a Heterogeneous Estrogen Receptor Expression Assessed by (18)F-FES PET

SIMPLE SUMMARY: About 10–20% of breast cancer patients have a heterogeneous estrogen receptor expression. The diagnosis and treatment strategy remains controversial in these patients, especially regarding the metastatic pattern. The aim of our study was to investigate the occurrence and properties o...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Yizhao, Du, Xinyue, Zhao, Yannan, Gong, Chengcheng, Hu, Shihui, You, Shuhui, Song, Shaoli, Hu, Xichun, Yang, Zhongyi, Wang, Biyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323202/
https://www.ncbi.nlm.nih.gov/pubmed/35884590
http://dx.doi.org/10.3390/cancers14143531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323202/
https://www.ncbi.nlm.nih.gov/pubmed/35884590
http://dx.doi.org/10.3390/cancers14143531

Ejemplares similares